Bio-Rad Laboratories Inc. (BIO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bio-Rad Laboratories Inc. (BIO:NYSE), powered by AI.

Current Price
$285.94
P/E Ratio
10.3
Market Cap
7.8B
Sector
Healthcare
What is the Bio-Rad Laboratories Inc. stock price forecast?

Bio-Rad Laboratories Inc. is currently trading at $285.94. View real-time AI analysis on Alpha Lenz.

What is Bio-Rad Laboratories Inc. insider trading activity?

View the latest insider trading data for Bio-Rad Laboratories Inc. on Alpha Lenz.

What is Bio-Rad Laboratories Inc.'s P/E ratio?

Bio-Rad Laboratories Inc.'s P/E ratio is 10.3.

Bio-Rad Laboratories Inc.

NYSE · BIO
$285.94-6.50(-2.22%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Bio-Rad Laboratories Inc.'s future dividend policy...
Alpha Chat Insight

Bio-Rad Laboratories Inc. trades at a P/E of 10.3 (undervalued) with solid ROE of 10.8%.

Ask for details

Company Overview

Bio-Rad Laboratories Inc. operates as a leading manufacturer and distributor of life science research products and clinical diagnostics systems. Established in 1952 and headquartered in Hercules, California, the company plays a pivotal role in the healthcare and medical research sectors. Bio-Rad provides a broad range of products for life science research, including reagents, instruments, and software used for techniques such as gel electrophoresis, chromatography, and polymerase chain reaction (PCR). These tools facilitate advancements in biology and medical research, aiding in the discovery of genetic information and the analysis of cell functions. In the clinical diagnostics realm, Bio-Rad offers solutions used to identify, track, and diagnose diseases through blood and tissue analysis, impacting critical areas like diabetes testing, blood typing, and autoimmune disease testing. With a comprehensive portfolio that supports innovation and efficiency in research laboratories and hospitals, Bio-Rad Laboratories Inc. significantly contributes to the improvement of diagnostic procedures and research methodologies, cementing its role as a key player in the enhancement of global health and medical science.

CEOMr. Norman D. Schwartz
SectorHealthcare
IndustryMedical Devices
Employees7,700

Company Statistics

FY 2025

Profile

$7.80BMarket Cap
$2.58BRevenue
0.00Shares Out
7,700Employees

Margins

51.87%Gross
18.61%EBITDA
8.46%Operating
38.54%Pre-Tax
29.42%Net

Valuation

10.26P/E
1.05P/B
3.02EV/Sales
18.00EV/EBITDA
20.81P/FCF

Growth (CAGR)

-2.68%Rev 3Yr
0.29%Rev 5Yr
-22.80%Op Inc 3Yr
-12.30%Op Inc 5Yr
N/ANet Inc 3Yr
-27.58%Net Inc 5Yr

Returns

7.62%ROA
10.84%ROE
10.48%ROIC

Financial Health

$529.80MCash & Cash Equivalents
$2.59BNet Debt
41.90%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bio-Rad Laboratories Inc. (ticker: BIO) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 7,700 employees. Market cap is $7.8B.

The current price is $285.94 with a P/E ratio of 10.26x and P/B of 1.05x.

ROE is 10.84% and operating margin is 8.46%. Annual revenue is $2.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bio-Rad Laboratories Inc. (BIO) Stock Forecast 2026 $285.94 — Price, Financials & Analyst Targets | Alpha Lenz